However, even our everyday habits — like the food we eat — may impact our health in unexpected ways. In a recent study from ...

If the low-risk prostate cancer doesn't progress, treatment and its associated ... The following recommended changes aim to ...

Men diagnosed with nonmetastatic low- and intermediate-risk prostate cancer up to 6 times more likely to die of other causes.

Prostate cancer doesn’t shout. It creeps. Quietly. Persistently. And for men of African ancestry — whether in Nassau, Abuja, or New York — it creeps faster, earlier, and with deadlier ...

According to analysts at Vantage Market Research, the Global Prostate Specific Antigen (PSA) Testing Market size is worth USD ...

Prostate cancer is the most prevalent cancer in Australia. This article discusses the limitations of PSA tests in determining ...

Prostate cancer is the most common cancer in Australia, with about 26,000 men diagnosed per year. The majority (more than 85% ...

Prostate cancer is the most common cancer in Australian men, often detected through PSA blood tests. New guidelines suggest ...

Most men who are treated for prostate cancer according to modern guidelines have good survival rates and the majority of ...

Charlottesville, Va.-based UVA Health is expanding its Stay in the Game initiative, a targeted prostate cancer screening program aimed at boosting early detection among Black men. Speaking with Becker ...

Dr. Nicholas James shares why it’s important to identify which patients with high-risk, non-metastatic prostate cancer will ...

New research in the July 2025 issue of JNCCN-Journal of the National Comprehensive Cancer Network finds that for people diagnosed with nonmetastatic low-risk prostate cancer later in life, and treated ...